• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume10, Issue1

A RARE INCIDENCE OF PARANEOPLASTIC MYOPATHY IN A CASE OF UROTHELIAL CARCINOMA- A CASE REPORT

    Dr Bhumika Vaishnav, Dr AVS SRIVATSAV, Dr.Nikitha Nimmagadda

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 1, Pages 1996-2001

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

There are several key observations on paraneoplastic myopathies: The risk of cancer associated with DM is very high, whereas risk of cancer associated with PM is mildly increased Most cancers develop within one year of the onset of myositis, although the risk remains high up to 5 years after diagnosis. The most common cancers associated with DM are adenocarcinoma, including lung, ovary, cervical, stomach, pancreas, colorectal and lymphoma, whereas PM is associated with a high risk of lymphoma. The clinical course of myopathy is closely linked with the course of cancer. Certain clinical features are associated with CAM including severe treatment resistant skin manifestations, severe muscle weakness, respiratory muscle weakness, and dysphagia, while some clinical features are protective such as arthritis, Raynaud, and ILD. Screening should be based on age, gender, ethnicity, and the geographic area of the patient; however, certain high-risk patients may require more extensive screening including tumor markers and thoracoabdominal-pelvic CT scans. Certain autoantibodies including anti-p155 and the absence of more common autoantibodies are associated with a higher risk of CAM, while the presence of antisynthetase autoantibodies lowers the risk for CAM. Although the pathogenesis of CAM is unclear, a plausible hypothesis is that immune responses generated against antigens commonly targeted in myositis are related to antitumor responses in affected individuals
Keywords:
  • PDF (557 K)
  • XML
(2023). A RARE INCIDENCE OF PARANEOPLASTIC MYOPATHY IN A CASE OF UROTHELIAL CARCINOMA- A CASE REPORT. European Journal of Molecular & Clinical Medicine, 10(1), 1996-2001.
Dr Bhumika Vaishnav, Dr AVS SRIVATSAV, Dr.Nikitha Nimmagadda. "A RARE INCIDENCE OF PARANEOPLASTIC MYOPATHY IN A CASE OF UROTHELIAL CARCINOMA- A CASE REPORT". European Journal of Molecular & Clinical Medicine, 10, 1, 2023, 1996-2001.
(2023). 'A RARE INCIDENCE OF PARANEOPLASTIC MYOPATHY IN A CASE OF UROTHELIAL CARCINOMA- A CASE REPORT', European Journal of Molecular & Clinical Medicine, 10(1), pp. 1996-2001.
A RARE INCIDENCE OF PARANEOPLASTIC MYOPATHY IN A CASE OF UROTHELIAL CARCINOMA- A CASE REPORT. European Journal of Molecular & Clinical Medicine, 2023; 10(1): 1996-2001.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 13
  • PDF Download: 42
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus